Patent 11786558 was granted and assigned to Ossium Health on October, 2023 by the United States Patent and Trademark Office.
Described herein are methods of cell therapies. Also described herein are methods of generating donor derived T cells in an organ transplant recipient, by administering bone marrow stem cells to the organ transplant recipient about 1 to about 30 days after the organ transplant recipient receives one or more organ transplants.